J&J Unit Aims to Thwart Sandoz’s Generic Doribax

Johnson & Johnson unit Janssen Pharmaceuticals slapped Sandoz with a patent infringement lawsuit in New Jersey federal court in an effort to keep the company from marketing its own version of the injectable antibiotic Doribax.
Law360